Atlas Trials

Inhibition of Plasma Kallikrein as a New Therapy for Lung Injury

Clinical trial NCT04848272 · UNKNOWN

Trial details

NCT number
NCT04848272
Sponsor
St Vincent's Institute of Medical Research
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Injury
Start date
2021-08-09
Primary completion
2024-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.